Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $992,549 - $1.22 Million
13,000 Added 10.83%
133,000 $10.7 Million
Q2 2022

Aug 05, 2022

BUY
$67.99 - $132.89 $5.47 Million - $10.7 Million
80,500 Added 203.8%
120,000 $8.94 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $2.26 Million - $3.12 Million
-24,000 Reduced 37.8%
39,500 $20.2 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $649,350 - $814,100
5,000 Added 8.55%
63,500 $34.1 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $320,130 - $429,540
-3,000 Reduced 4.88%
58,500 $32 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $1.09 Million - $1.46 Million
13,500 Added 28.13%
61,500 $26.3 Million
Q1 2021

May 12, 2021

BUY
$84.79 - $104.74 $4.07 Million - $5.03 Million
48,000 New
48,000 $17.3 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Montanaro Asset Management LTD Portfolio

Follow Montanaro Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montanaro Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Montanaro Asset Management LTD with notifications on news.